GJB2 and neoplasm: Interestingly, when comparing Cre- and Cre+ mice in which 3 months had passed before Cx26 knockout, DMBA-treated Cre+ mice had a significantly (p < 0.0001, logrank test) lower number of mice that remained tumour free compared to Cre- mice over the duration of the experiment (Figure 2A).